Skip to content

Transcranial Near-Infrared Photobiomodulation for Postpartum Anxiety: A Randomized Controlled Trial

Transcranial Near-Infrared Photobiomodulation for Postpartum Anxiety: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600118726
Enrollment
Unknown
Registered
2026-02-10
Start date
2026-02-24
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum Anxiety

Interventions

Experimental Group:Interventional Device: Transcranial photobiomodulation device Core Parameters: Irradiation wavelength: 1064 nm
Output power: 250 mW Irradiation Site: Parietal lobe, bilateral prefrontal lobes Intervention Duration and Frequency Single irradiation duration: 20 minutes per session Intervention time points: On th
the implementation of each intervention shall be recorded.
Control Group:Same device and operation as the intervention group, no effective irradiation.

Sponsors

Yan'an City Hospital of TCM
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Age 18–45 years old; 2. Full-term pregnancy (>=37 weeks), planning to give birth in this hospital and complete post-partum hospitalization observation; 3. Able to understand the research process and sign the informed consent form; 4. Acceptable to have equipment contact and irradiation on the forehead (no obvious skin contraindications).

Exclusion criteria

Exclusion criteria: 1.The parturient or their family members refuse. 2. Complicated with oral ulcers, bleeding, or inflammation. 3. Complicated with diabetes or thyroid disease. 4. A clear history of past or current mental disorders, bipolar disorder, or at risk of acute suicide. 5. A clear history of major neurological diseases (such as a history of epileptic seizures, etc.) or a history of photosensitivity-related diseases. 6. Frontal skin damage, infection, severe dermatitis, or areas unsuitable for contact after surgery. 7. Severe postpartum complications requiring ICU/emergency treatment, making it impossible to complete the research process.

Design outcomes

Primary

MeasureTime frame
Incidence rate of anxiety;

Secondary

MeasureTime frame
Incidence rate of depression;Salivary metabolomics;Sleep quality;Pain score;

Countries

China

Contacts

Public ContactZhao Huiling

Yan'an City Hospital of TCM

zhlyingxi@163.com+86 178 2911 3804

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026